scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1600-6143.2007.01665.X |
P698 | PubMed publication ID | 17217438 |
P50 | author | Yvon Lebranchu | Q33292943 |
P2093 | author name string | H Nivet | |
Valérie Chatelet | |||
M Buchler | |||
J-M Halimi | |||
I Laouad | |||
A Al-Najjar | |||
J-F Marlière | |||
P433 | issue | 3 | |
P304 | page(s) | 618-625 | |
P577 | publication date | 2007-01-11 | |
P1433 | published in | American Journal of Transplantation | Q4744273 |
P1476 | title | Urinary albumin excretion and the risk of graft loss and death in proteinuric and non-proteinuric renal transplant recipients | |
P478 | volume | 7 |
Q42724173 | A new clinical prediction tool for 5-year kidney transplant outcome |
Q90003518 | Accelerated podocyte detachment early after kidney transplantation is related to long-term allograft loss of function |
Q36285590 | Albuminuria-reducing effect of angiotensin II receptor blocker plus hydrochlorothiazide combination therapy in renal transplant recipients |
Q26771406 | Cardiovascular risk factors following renal transplant |
Q37641382 | Derivation of a Predictive Model for Graft Loss Following Acute Kidney Injury in Kidney Transplant Recipients |
Q83534471 | Glucose intolerance in renal transplant recipients is associated with increased urinary albumin excretion |
Q37078089 | Minimal proteinuria one year after transplant is a risk factor for graft survival in kidney transplantation |
Q37964276 | New options and perspectives for proteinuria management after kidney transplantation. |
Q89668710 | One-year Outcome of Everolimus With Standard-dose Tacrolimus Immunosuppression in De Novo ABO-incompatible Living Donor Kidney Transplantation: A Retrospective, Single-center, Propensity Score Matching Comparison With Mycophenolate in 42 Transplants |
Q52668909 | Predictive value of spot versus 24-hour measures of proteinuria for death, end-stage kidney disease or chronic kidney disease progression. |
Q38461792 | Pretransplant IFN-γ ELISPOT assay as a potential screening test to select immunosuppression protocols for patients receiving basiliximab induction therapy |
Q40997354 | Proteinuria 1 year after renal transplantation is associated with impaired graft survival in children |
Q46429375 | Proteinuria and renal transplantation |
Q34483895 | Proteinuria as a Noninvasive Marker for Renal Allograft Histology and Failure: An Observational Cohort Study |
Q35154685 | Regression of cardiac growth in kidney transplant recipients using anti-m-TOR drugs plus RAS blockers: a controlled longitudinal study |
Q51278524 | Relationship Between Albuminuria During the First Year and Antibody-Mediated Rejection in Protocol Biopsies in Kidney Transplant Recipients. |
Q91611032 | Relationship between early proteinuria and long term outcome of kidney transplanted patients from different decades of donor age |
Q41655077 | Relationships Between Metabolic Syndrome, Microalbuminuria, and C-Reactive Protein in Turkish Kidney Transplant Recipients. |
Q63681840 | Renal Function, Albuminuria, and the Risk of Cardiovascular Events After Kidney Transplantation |
Q37704938 | The effect of combination therapy with rituximab and intravenous immunoglobulin on the progression of chronic antibody mediated rejection in renal transplant recipients. |
Q34751942 | The urine albumin-to-creatinine ratio: assessment of its performance in the renal transplant recipient population |
Q46225652 | Transplantation: Proteinuria in kidney transplantation: an ongoing story |
Q40260780 | Urinary Markers of Fibrosis and Risk of Cardiovascular Events and Death in Kidney Transplant Recipients: The FAVORIT Trial |
Q91926310 | Urine Albumin Creatinine Ratio May Predict Graft Function After Kidney Transplant |
Q36640019 | Urine high and low molecular weight proteins one-year post-kidney transplant: relationship to histology and graft survival |
Q36211914 | Utilizing Estimated Creatinine Excretion to Improve the Performance of Spot Urine Samples for the Determination of Proteinuria in Kidney Transplant Recipients |
Q61548355 | When evidence doesn't generalise: the case of ACE inhibition |
Search more.